ECOG-ACRIN EA2176

A Randomized Phase III Study of Immune Checkpoint Inhibition with Chemotherapy in Treatment-Naïve Metastatic Anal Cancer Patients

Objective

This phase III trial compares the addition of nivolumab to chemotherapy (carboplatin and paclitaxel) versus usual treatment (chemotherapy alone) for the treatment of anal cancer that has spread to other places in the body (metastatic).

NCT#04444921

Clinical Trial Categories

• Gastrointestinal & Gastroesophageal Cancer

Contact

NH Oncology Hematology Clinical Research Dept. at (603) 224-2556